Global News

[ad_1] According to a recent study published in the Journal of Clinical Endocrinology & Metabolism of the Endocrine Society, mothers with obesity may share the disease`s risk with their daughters but not with their sons. Obesity is a common, serious and costly disease affecting nearly half of the adults and 20 percent of children in the United States.  People with obesity are at higher risk of developing diabetes, high blood pressure, heart issues, and many other conditions. "These findings highlight that girls born to mothers who have obesity or have high amounts of body fat may be at higher risk of gaining excess body fat themselves," said Rebecca J. Moon, B.M., Ph.D., M.R.C.P.C.H., of the MRC Lifecourse Epidemiology Centre, University of Southampton in Southampton, U.K.  "Further studies are needed to understand why this is happening, but our findings suggest that approaches to addressing body weight and composition should start very early in life, parti

[ad_1] Hopes are sky-high for Eli Lilly's recently launched weight loss drug Zepbound. Investors will be tuning into the company's fourth quarter earnings call on Feb. 6, eager to hear more about how that rollout is going. One key statistic will be the number of commercial health insurers providing coverage of the drug, which was approved by the Food and Drug Administration on Nov. 8. Lilly also is expected to reveal its outlook for 2024 for the first time. Zepbound, a once-a-week injection, has only been available in pharmacies since early December, but the average analyst expects that the drug's sales reached $75 million in the fourth quarter, according to StreetAccount. More importantly, by the end of 2024, analysts expect sales to ramp up to $3.79 billion, then more than double to $7.83 billion by 2025. Those estimates have been creeping higher heading into Eli Lilly's report, and analysts see the potential for further upside when Lilly provides its outlook. &#

[ad_1] CALIFORNIA: Researchers at the Fred Hutchinson Cancer Research Centre in the United States, led by Mroj Alassaf, have established a relationship between obesity and neurodegenerative illnesses like as Alzheimer's disease. The study, which used the common fruit fly, found that a high-sugar diet -- a hallmark of obesity -- induces insulin resistance in the brain, which lowers the ability to eliminate neuronal debris, raising the risk of neurodegeneration . The study, which was published in the open access journal PLOS Biology, will have an impact on medications meant to minimise the chance of acquiring neurodegenerative illnesses. Although obesity is known to be a risk factor for neurodegenerative disorders like Alzheimer's disease and Parkinson's disease, exactly how one leads to the other remains a mystery. The new study focused on answering this question by taking advantage of the similarity between humans and fruit flies. Having previously shown that a hig

[ad_1] Pregnancy-related obesity brings with it complicated issues that demand extensive understanding and preventive care. It is critical to highlight the complex concerns that obesity in mothers poses to both the growing fetus and the expecting mother. The implications of maternal obesity extend beyond pregnancy, impacting the long-term health of both the mother and child. Understanding these complexities is crucial for effective intervention and management. According to the WHO, more than 1 billion people globally are suffering from obesity – 650 million adults, 340 million youth, and 39 million children. In a place where more than one-third of the population is obese, highlighting the adverse effects of this epidemic is of immense importance. How Obesity Affects Female Reproductive Health Dr Garima Sawhney, Senior Gynaecologist and Co-founder, Pristyn Care shares, "Maternal obesity increases the likelihood of experiencing a few issues throughout pregnancy. The prim

[ad_1] Sons of women with polycystic ovary syndrome (PCOS) are three times more likely to develop obesity, a new study has shown. The study from Karolinska Institutet, Sweden, said that it highlighted a previously unknown risk of passing PCOS-related health problems across generations through the male side of a family. The study is published in the journal Cell Reports Medicine. Using registry data and mouse models, the researchers determined if and how PCOS-like traits are passed from mothers to their sons. Just over 460,000 sons born in Sweden between July 2006 and December 2015 were included in the registry study. Of these, roughly 9,000 were sons of women with PCOS. The researchers then identified which of the children were obese. "We discovered that sons of women with PCOS have a threefold risk of obesity and of having high levels of "bad" cholesterol, which increases the risk of developing insulin resistance and type 2 diabetes later in life," said l

[ad_1] If you are looking to lose weight, a few types of healthy seeds can go a long way in helping you in your journey! Yes, you read that right! Irrespective of whether you have just started your weight-loss journey or have been on the path for a while, these tiny seeds have the required power and nutrition to make a difference. These seeds are loaded with fibre and contain omega-3s, vitamins, minerals, and protein, all of which can maintain hormonal balance and manage weight. Having said that, these seeds are not a magical solution for weight loss. But by making them a part of your daily diet, along with regular exercise, can help you to a great extent. Here are the top 5 seeds for weight-loss that you can add to your diet: 1) Pumpkin seeds: Packed with the goodness of protein, fibre, phosphorus, monounsaturated fats and omega-6 fats, pumpkin seeds are one of the most commonly consumed types of seeds. Studies have shown that the magnesium in pumpkin seeds helps regulate b

[ad_1] When you have a child, each tiny milestone of theirs brings you happiness and joy. Be it the first time they grab your finger or the first few steps they take, each development makes your heart leap with joy. But, with each new step, parents are also constantly worried about their health and well-being. Parenting is often challenging and takes ample hard work and responsibilities, especially for the new parents as the formative years of children hold the utmost importance to shape their lives.  One of the biggest worries of a parent is to make their kids eat nutritious and healthy meals that help them to grow. However, Kids often get fussy and demand junk food with unhealthy fats and added sugars. They also increase children’s chances of developing childhood obesity which causes multiple risk factors for many health complications in later life. Dr Pallavi Rao Chaturvedi, a parenting coach, educator, and founder of Get Set Parent shares few ideas to raise your kids in a

[ad_1] Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Friday said it will acquire Versanis, a privately held obesity drug maker , for up to $1.93 billion to boost the pharmaceutical giant's weight loss treatment portfolio.  Eli Lilly agreed to pay Versanis shareholders in cash, which will consist of an upfront payment and potentially subsequent payments if Versanis achieves certain "development and sales milestones." Oakland, California-based Versanis, which was founded in 2021 by biotech investment firm Aditum Bio, has one experimental drug for obesity and potentially other conditions. Eli Lilly's stock price rose 3% on Friday following the announcement. The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which began last year after Novo Nordisk' s blockbuster injections Wegovy and Ozempic boomed in popularity.  An est

[ad_1] In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter in Los Angeles, April 17, 2023. Mario Tama | Getty Images The European Union's drug regulator on Tuesday said it has broadened an investigation into the risk of suicidal thoughts and self-injury among patients taking Novo Nordisk 's Ozempic, Wegovy and Saxenda drugs to include other weight loss and diabetes medications.  The European Medicines Agency didn't specify which additional drugs are now included in the investigation. But it could potentially include Eli Lilly 's diabetes drug Mounjaro, which is approved in the EU . Other companies such as Pfizer and Amgen are developing similar products.  The EMA said it is now evaluating about 150 reports of possible cases of self-injury and suicidal thoughts in patients taking weight loss and diabetes drugs. It's still unclear if the medicines caused the events or whether they are linked to patients' underlying

[ad_1] A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Only around one-third of patients prescribed weight loss drugs such as Novo Nordisk 's blockbuster injection Wegovy continued to take it a year later — but total health-care costs for the entire group soared, according to an analysis shared with CNBC on Tuesday. The annual health-care cost for patients before they started a weight loss medication was $12,371 on average, said the analysis from Prime Therapeutics , one of the largest pharmacy benefit managers in the U.S.  That cost of care jumped by nearly 60% to $19,657 on average after patients started treatment, the analysis said. And a group of patients in the analysis who didn't take a weight loss drug saw their health-care costs decrease by 4% on average during the same time period.  The analysis reviewed U.S. pharmacy and medical claims data for more

[ad_1] Body mass index (BMI) may not increase mortality independently of other risk factors in adults, according to a new study that stressed the need for incorporating other factors. The prevalence of overweight and obesity has risen dramatically over the last 25 years, and it is well-established that elevated BMI can contribute to several cardio-metabolic conditions. However, studies that have analysed the association between BMI and all-cause mortality have been inconsistent. To understand, a team from Rutgers University in the US retrospectively studied data on 554,332 US adults. Of these, about 35 per cent had a BMI between 25 and 30, which is typically defined as overweight, and 27.2 per cent had a BMI above or equal to 30, typically defined as obese. Over a median follow-up of nine years and a maximum follow-up of 20 years, the researchers observed 75,807 deaths. The risk of all-cause mortality was similar across a wide range of BMI categories. For older adults, there w